Showing 1 - 20 results of 29 for search 'Samuel Z Goldhaber', query time: 0.08s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis. by Navkaranbir S Bajaj, Muthiah Vaduganathan, Arman Qamar, Kartik Gupta, Ankur Gupta, Harsh Golwala, Javed Butler, Samuel Z Goldhaber, Mandeep R Mehra
Published 2019-04-01
Article -
8
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy by Robert Frank Cornell, Samuel Z. Goldhaber, Brian G. Engelhardt, Javid Moslehi, Madan Jagasia, Daryl Patton, Shelton Harrell, Robert Hall, Houston Wyatt, Greg Piazza
Published 2019-02-01
Article -
9
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial by Megan K. Yee, C. Michael Gibson, Tarek Nafee, Mathieu Kerneis, Yazan Daaboul, Serge Korjian, Gerald Chi, Fahad AlKhalfan, Adrian F. Hernandez, Russell D. Hull, Alexander T. Cohen, Samuel Z. Goldhaber
Published 2019-04-01
Article -
10
Machine learning to predict venous thrombosis in acutely ill medical patients by Tarek Nafee, C. Michael Gibson, Ryan Travis, Megan K. Yee, Mathieu Kerneis, Gerald Chi, Fahad AlKhalfan, Adrian F. Hernandez, Russell D. Hull, Ander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber
Published 2020-02-01
Article -
11
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification by C. Michael Gibson, Alex C. Spyropoulos, Alexander T. Cohen, Russell D. Hull, Samuel Z. Goldhaber, Roger D. Yusen, Adrian F. Hernandez, Serge Korjian, Yazan Daaboul, Alex Gold, Robert A. Harrington, Gerald Chi
Published 2017-06-01
Article -
12
Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy by C. Michael Gibson, Serge Korjian, Gerald Chi, Yazan Daaboul, Purva Jain, Douglas Arbetter, Samuel Z. Goldhaber, Russel Hull, Adrian F. Hernandez, Renato D. Lopes, Alex Gold, Alexander T. Cohen, Robert A. Harrington
Published 2017-07-01
Article -
13
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals by Anne-Céline Martin MD, PhD, Wei Huang PhD, Samuel Z. Goldhaber MD, Russell D. Hull MD, Adrian F. Hernandez MD, Charles-Michael Gibson MD, Frederick A. Anderson PhD, Alexander T. Cohen MD
Published 2019-10-01
Article -
14
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion by Jonathan S. Williams, Paula J. Autori, Stephen K. Kidd, Gregory Piazza, Molly C. Connors, Charles A. Czeisler, Karine D. Scheuermaier, Jeanne Duffy, Elizabeth B. Klerman, Frank A. Scheer, Marjorie Kozak, Sheila M. Driscoll, Samuel Z. Goldhaber
Published 2018-01-01
Article -
15
Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis by Orly Leiva, Umberto Campia, Julia Snyder, Briana M. Barns, Samantha Rizzo, Candrika D. Khairani, Andrew Brunner, Hanny Al‐Samkari, Rebecca Karp Leaf, Rachel Rosovsky, Katayoon Goodarzi, Larissa Bornikova, Amir Fathi, Samuel Z. Goldhaber, Gabriela Hobbs, Gregory Piazza
Published 2022-07-01
Article -
16
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE by Walter Ageno, Alfredo Farjat, Sylvia Haas, Jeffrey I. Weitz, Samuel Z. Goldhaber, Alexander G. G. Turpie, Shinya Goto, Pantep Angchaisuksiri, Joern Dalsgaard Nielsen, Gloria Kayani, Sebastian Schellong, Henri Bounameaux, Lorenzo G. Mantovani, Paolo Prandoni, Ajay K. Kakkar
Published 2021-02-01
Article -
17
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial by C. Michael Gibson, Lisa K. Jennings, Gerald Chi, Megan K. Yee, Rim Halaby, Tarek Nafee, Fahad AlKhalfan, Mathieu Kerneis, Serge Korjian, Yazan Daaboul, Samuel Z. Goldhaber, Russel D. Hull, Adrian F. Hernandez, Alexander T. Cohen, Robert A. Harrington
Published 2018-01-01
Article -
18
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy by Kevin McLaughlin PharmD, BCPS, Jessica Rimsans PharmD, BCPS, Katelyn W. Sylvester PharmD, BCPS, CACP, John Fanikos Rph, MBA, David M. Dorfman MD, PhD, Patricia Senna MT, ASCP, Jean M. Connors MD, Samuel Z. Goldhaber MD
Published 2019-09-01
Article -
19
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism by Behnood Bikdeli, David Jiménez, Jorge del Toro, Gregory Piazza, Agustina Rivas, José Luis Fernández‐Reyes, Ángel Sampériz, Remedios Otero, José María Suriñach, Carmine Siniscalchi, Javier Miguel Martín‐Guerra, Joaquín Castro, Alfonso Muriel, Gregory Y. H. Lip, Samuel Z. Goldhaber, Manuel Monreal
Published 2021-09-01
Article -
20
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE by Carlos Jerjes-Sánchez, David Rodriguez, Alfredo E. Farjat, Gloria Kayani, Peter MacCallum, Renato D. Lopes, Alexander G.G. Turpie, Jeffrey I. Weitz, Sylvia Haas, Walter Ageno, Shinya Goto, Samuel Z. Goldhaber, Pantep Angchaisuksiri, Joern Dalsgaard Nielsen, Sebastian Schellong, Henri Bounameaux, Lorenzo G. Mantovani, Paolo Prandoni, Ajay K. Kakkar
Published 2021-01-01
Article